ASSIGN

Assign Clinical Research is a specialized European contract research organization (CRO) that provides comprehensive clinical development services to the pharmaceutical and biotechnology industries. Headquartered in Innsbruck, Austria, the company focuses on Phase I and Phase II clinical trials, offering expertise in clinical trial management, data management, biostatistics, and regulatory affairs. Assign is particularly recognized for its work in complex therapeutic areas such as oncology, immunology, and infectious diseases. In 2018, the company was acquired by KCR (Kenes Clinical Research), a global CRO, to strengthen its service offerings and geographic footprint in the DACH region (Germany, Austria, and Switzerland). Today, Assign operates as a strategic hub within KCR's international network, leveraging its high-quality data capabilities to support early-stage drug development.